Vanguard Asset Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
GJL
Vanguard Asset Management's CLB Position: Q3 2026 in Review
Vanguard Asset Management increased its Core Laboratories (CLB) stake by 41% in Q3 2026, buying an estimated $135K and bringing the position to 40,466 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #2270.
Vanguard Asset Management first reported a position in CLB in Q1 2026 and has held it in 3 quarters since. The position peaked at $483K in Q1 2026. 180 funds tracked by Wall St. Rank hold CLB as of Q3 2026.
- Vanguard Asset Management held 40,466 shares of Core Laboratories worth $393K as of Q3 2026.
- Vanguard Asset Management bought 11,695 Core Laboratories shares in Q3 2026, an estimated $135K.
- Core Laboratories made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2270 holding.
- Vanguard Asset Management first reported a position in Core Laboratories in Q1 2026 and has held it in 3 quarters since.
- Vanguard Asset Management's Core Laboratories position peaked at $483K in Q1 2026.
- 180 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.